Ferroquine clinical trials
How each study uses ferroquine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the ferroquine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Ferroquine (SSR97193)
- 3
Studies by the year they started
4 studies that test it; most in 2007 (1)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2018 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Artefenomel (1) · ZY-19489 (1)
Studies
Open first, then newest update. How each study uses ferroquine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination ZY19489-Ferroquine in Adult Asymptomatic Plasmodium Falciparum CarriersRecruitingPhase 1Zydus Lifesciences LimitedNCT05911828Written as ZY19489 + Ferroquine (FQ)How we know
- Study to Investigate the Clinical and Parasiticidal Activity and Pharmacokinetics of Different Doses of Artefenomel and Ferroquine in Patients With Uncomplicated Plasmodium Falciparum MalariaCompletedPhase 2SanofiNCT03660839Written as Ferroquine (SSR97193)How we know
- Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum MalariaTerminatedPhase 2SanofiNCT00988507Written as Ferroquine (SSR97193)How we know
- A Comparative Safety and Activity Study With Ferroquine Associated With Artesunate Versus Amodiaquine Associated With Artesunate in African Adult Patients With Uncomplicated MalariaCompletedPhase 1/2SanofiNCT00563914Written as ferroquine (SSR97193)How we know
Given beside what is tested · 1 — ferroquine is usual care or a partner of the new treatment
Codes
What other systems call ferroquine · ClinicalTrials.gg INT004586
- MeSH (NLM) C479230ferroquineConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 8D81JS19ETFERROQUINEConfirmed FDA, NLM, Wikidata
- Wikidata Q3069733ferroquineConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C171721FerroquineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C479230 | ferroquine | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 8D81JS19ET | FERROQUINE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q3069733 | ferroquine | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C171721 | Ferroquine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.